97309325
Mar 12, 2022
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease
Pharmaceuticals